Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GO-RAISE: Golimumab in Active Ankylosing Spondylitis
NCT00265083Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2005
- Primary completion
- Mar 2007
- Modality
- Monoclonal Antibodies
- Countries
- 9
01
Overview
A Phase 3 trial of golimumab in ankylosing spondylitis (AS), sponsored by Janssen Pharmaceutical. Started Dec 2005; status: completed.
02
Drugs
golimumab
03
Conditions
ankylosing spondylitis (AS)
Beyond the preview
Go deeper on NCT00265083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265083.